We use cookies to improve your experience on this website. Read More Allow Cookies

Latest News From BioPharmaChem

    September 2019

  • PCI boosts Ireland investment pre-Brexit with new clinical facility

    PCI boosts Ireland investment pre-Brexit with new clinical facility

    02 September, 2019

    As part of its global network expansion strategy, PCI Pharma Services is investing in a new dedicated clinical facility near Dublin, Ireland, which will provide space for secondary packaging, storage, logistics, and distribution.

    Continue Reading »

  • Xperi Corporation Celebrates Opening of New Galway Office with Plans to Expand its Innovative R&D Team

    Xperi Corporation Celebrates Opening of New Galway Office with Plans to Expand its Innovative R&D Team

    06 September, 2019

    Xperi Corporation, a Silicon Valley based, publicly traded technology company with two subsidiaries in Ireland – FotoNation in Galway and DTS in Limerick – celebrated the official opening of its new FotoNation office in Galway, Ireland. Through an increased commitment to research and development (R&D) investment in Ireland, Xperi’s DTS subsidiary plans to establish an innovation hub at its new Galway location. In addition, the Company is also working to expand its local engineering talent around high-potential growth initiatives, including premium audio, computational imaging, computer vision, and machine learning capabilities, just to name a few. These investments are expected to result in at least 50 new Ireland-based engineering positions over the next several years, with further R&D investment expected that would contribute to additional employment opportunities in Ireland. The expansion project is supported by the Irish Government through IDA Ireland.

    Continue Reading »

  • Irish pharmaceutical sector made €47.7 BILLION of goods in 2018 as figures show pill plant profits are healthy

    10 September, 2019

    Medicines for insomniacs, asthmatics, diabetics, and transplant recipients are a selection of the vast array of medical marvels manufactured on Irish soil. According to the latest CSO figures, the pharmaceutical sector produced more than €47.7billion in goods last year — up more than seven per cent on the previous year’s tally of €44.5billion. The sector dominates its production rivals and accounts for 39 per cent of Ireland’s manufacturing landscape. Ireland’s pharma industry is worth double that of the next largest industrial production rival — food products — which produced just €23.5billion.

    Continue Reading »

  • Tipperary firm ups the fight against cancer

    Tipperary firm ups the fight against cancer

    11 September, 2019

    An oncology drug which is easier to administer to women suffering from ovarian cancer than those currently available on the market is the first of a number of innovative drugs under development at Shorla Pharma in Clonmel, Co Tipperary.

    Continue Reading »

  • Cancer drug innovator named Ireland's Best Young Entrepreneur

    15 September, 2019

    A cancer drug innovator from Waterford has been named as Ireland's Best Young Entrepreneur (IBYE) for 2019. Sharon Cunningham - co-founder of Shorla Pharma - won the top award at a ceremony in Dublin, securing a total investment fund of €40,000.

    Continue Reading »

  • Irish exports hit near record €13.6bn in July despite global slowdown

    Irish exports hit near record €13.6bn in July despite global slowdown

    16 September, 2019

    The value of Irish goods exports hit a near record €13.6 billion in July despite signs of a major slowdown in global trade and the ongoing Brexit uncertainty. The latest trade figures from the Central Statistics Office (CSO) show exports jumped by over €2 billion or 18 per cent in July compared with the previous month.

    Continue Reading »